- Home
- VSA vs KLTO Comparison
VSA vs KLTO Comparison
Compare VSA & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- KLTO
- Stock Information
- Founded
- VSA 2002
- KLTO 2019
- Country
- VSA China
- KLTO United States
- Employees
- VSA N/A
- KLTO N/A
- Industry
- VSA
- KLTO
- Sector
- VSA
- KLTO
- Exchange
- VSA NYSE
- KLTO NYSE
- Market Cap
- VSA 4.2M
- KLTO 4.8M
- IPO Year
- VSA N/A
- KLTO N/A
- Fundamental
- Price
- VSA $0.70
- KLTO $0.17
- Analyst Decision
- VSA
- KLTO
- Analyst Count
- VSA 0
- KLTO 0
- Target Price
- VSA N/A
- KLTO N/A
- AVG Volume (30 Days)
- VSA 187.6K
- KLTO 152.4K
- Earning Date
- VSA 05-21-2025
- KLTO 05-19-2025
- Dividend Yield
- VSA N/A
- KLTO N/A
- EPS Growth
- VSA N/A
- KLTO N/A
- EPS
- VSA N/A
- KLTO N/A
- Revenue
- VSA $190,004,403.00
- KLTO N/A
- Revenue This Year
- VSA $97.94
- KLTO N/A
- Revenue Next Year
- VSA N/A
- KLTO N/A
- P/E Ratio
- VSA N/A
- KLTO N/A
- Revenue Growth
- VSA N/A
- KLTO N/A
- 52 Week Low
- VSA $0.36
- KLTO $0.11
- 52 Week High
- VSA $19,500.00
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- KLTO N/A
- Support Level
- VSA N/A
- KLTO N/A
- Resistance Level
- VSA N/A
- KLTO N/A
- Average True Range (ATR)
- VSA 0.00
- KLTO 0.00
- MACD
- VSA 0.00
- KLTO 0.00
- Stochastic Oscillator
- VSA 0.00
- KLTO 0.00
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.